Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood Symptoms: An Open-label Feasibility Study of ACT-PM

NCT06462391 is registered in ClinicalTrials.gov with Women's College Hospital as lead sponsor.

NCT NCT06462391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06462391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood Symptoms: An Open-label Feasibility Study of ACT-PM
Lead sponsor
Women's College Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 1, 2024
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

premenstrual dysphoric disorder, premenstrual exacerbation of mood disorder